No article text was recorded for this version.
tumor hypoxia
Version 2 of 280 papers113 conceptsfrozen 2026-10-04
Papers in this version
- Blog: A Highly Charged Positive Cage Causes Simultaneous Enhancement of Type‐II and O<sub>2</sub>‐Independent‐Type‐I Photodynamic Therapy via One‐/Two‐Photon Stimulation and Tumor Immunotherapy via PANoptosis and Ferroptosis
- Blog: Nuclear Factor-κB–Dependent Epithelial to Mesenchymal Transition Induced by HIF-1α Activation in Pancreatic Cancer Cells under Hypoxic Conditions
- Blog: Factors Contributing to the High Malignancy Level of Cholangiocarcinoma and Its Epidemiology: Literature Review and Data
- Blog: Tumor‐Homing Phage Nanofibers for Nanozyme‐Enhanced Targeted Breast Cancer Therapy
- Blog: Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer
- Blog: Improved sensitization effect of sunitinib in cancer cells of the esophagus under hypoxic microenviroment
- Blog: Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model
- Blog: Persistent Regulation of Tumor Hypoxia Microenvironment via a Bioinspired Pt‐Based Oxygen Nanogenerator for Multimodal Imaging‐Guided Synergistic Phototherapy
- Blog: Modeling cellular response in large-scale radiogenomic databases to advance precision radiotherapy
- Blog: Biomimetic Metal-Organic Framework Nanoparticles for Synergistic Combining of SDT-Chemotherapy Induce Pyroptosis in Gastric Cancer
- Blog: JFK Is a Hypoxia-Inducible Gene That Functions to Promote Breast Carcinogenesis
- Blog: Biomaterials-based phototherapy for bacterial infections
- Blog: Study on heterogeneity of vascularity and cellularity via multiparametric MRI habitat imaging in breast cancer
- Blog: Deep-learning and MR images to target hypoxic habitats with evofosfamide in preclinical models of sarcoma
- Blog: Photo-controlled co-delivery of verteporfin and acriflavine via platelets achieves potentiated glioblastoma-targeted photodynamic therapy
- Blog: An activatable unimolecular phototheranostic agent for synergistic chemo-photodynamic therapy
- Blog: Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia
- Blog: Analysis of an engineered organoid model of pancreatic cancer identifies hypoxia as a contributing factor in determining transcriptional subtypes
- Blog: Tumor necrosis-informed prognostic nomogram for clear cell renal cell carcinoma model development and clinical validation
- Blog: Predictive value of dynamic change of haemoglobin levels during therapy on treatment outcomes in patients with Enneking stage IIB extremity osteosarcoma
- Blog: Targeted DNA Nanomachine Enables Specific miRNA‐Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy
- Blog: NIR diagnostic imaging of triple-negative breast cancer and its lymph node metastasis for high-efficiency hypoxia-activated multimodal therapy
- Blog: Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcoma
- Blog: NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway
- Blog: Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation
- Blog: Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity
- Blog: Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation
- Blog: Interventional Photothermal Therapy Enhanced Brachytherapy: A New Strategy to Fight Deep Pancreatic Cancer
- Blog: Nanoformulation-based drug delivery systems for the treatment of gastric cancer: recent developments and future prospects
- Blog: Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma
- Blog: The Potential of Low Press and Hypoxia Environment in Assisting Pan-cancer Treatment
- Blog: ONECUT2 is a driver of neuroendocrine prostate cancer
- Blog: Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA
- Blog: LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells
- Blog: FLASH-RT for pulmonary protection: a comprehensive review of mechanisms, technological advances, and clinical translation
- Blog: Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom
- Blog: Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth
- Blog: Development of a biomimetic thyroid acellular scaffold as a 3D platform for modeling thyroid cancer aggressiveness and drug resistance
- Blog: Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology
- Blog: Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors
- Blog: Nanoparticle-based radiosensitization strategies for improving radiation therapy
- Blog: Progression in low‐intensity ultrasound‐induced tumor radiosensitization
- Blog: Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration
- Blog: Brain Tumor Characterization Using Multiple <scp>MR</scp> Parameters From Multi‐Contrast <scp>EPI</scp> With Keyhole (<scp>GE</scp>‐<scp>SE EPIK</scp>) Including Oxygen Extraction Fraction: A Comparison to O‐(2‐[<scp>18F</scp>]Fluoroethyl)‐L‐Tyrosine (FET) Positron Emission Tomography
- Blog: Ultrasound-triggered and Glycosylation Inhibition-enhanced Tumor Piezocatalytic Immunotherapy
- Blog: Recent advances and prospects of carbon dots in cancer nanotheranostics
- Blog: Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
- Blog: Yi Ai Fang, a traditional Chinese herbal formula, impacts the vasculogenic mimicry formation of human colorectal cancer through HIF-1α and epithelial mesenchymal transition
- Blog: Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions
- Blog: Safe Brain Tumor Resection Does not Depend on Surgery Alone - Role of Hemodynamics
- Blog: Photochemical and biological dual-effects enhance the inhibition of photosensitizers for tumour growth
- Blog: Covalent organic polymer induces apoptosis of liver cancer cells via photodynamic and photothermal effects
- Blog: Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple–negative breast cancer cells
- Blog: New advances in circulating tumor cell‑mediated metastasis of breast cancer (Review)
- Blog: Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
- Blog: ALA-based photodynamic priming in murine skin increases blood flow and oxygenation
- Blog: How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?
- Blog: Novel Type I/II Carbazole/Benzindole Photosensitizers Achieve Chemo-Photodynamic Synergistic Therapy for Suppressing Solid Tumors and Drug-Resistant Bacterial Infections
- Blog: Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
- Blog: <i><scp>ARNT</scp></i>/<scp>HIF</scp>‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
Showing 60 of 80 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_tumor_hypoxia_dac01436,
title = {tumor hypoxia},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-hypoxia/rdr_dac014360ba846a6adbcb83bcb815f17},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_tumor_hypoxia_dac01436_v2,
title = {tumor hypoxia},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-hypoxia/rdr_dac014360ba846a6adbcb83bcb815f17/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}